Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 New perspectives in chronic granulomatous disease.

× No keyword cloud information.

38 in total

1. Recombinant interferon gamma augments phagocyte superoxide production and X-chronic granulomatous disease gene expression in X-linked variant chronic granulomatous disease.

Authors: R A Ezekowitz; S H Orkin; P E Newburger
Journal: J Clin Invest Date: 1987-10 Impact factor: 14.808

Review 2. Reverse genetics and human disease.

Authors: S H Orkin
Journal: Cell Date: 1986-12-26 Impact factor: 41.582

3. Monocyte kinetic studies in normal and disease states.

Authors: G Meuret; G Hoffmann
Journal: Br J Haematol Date: 1973-03 Impact factor: 6.998

4. Activation of human neutrophil nicotinamide adenine dinucleotide phosphate, reduced (triphosphopyridine nucleotide, reduced) oxidase by arachidonic acid in a cell-free system.

Authors: J T Curnutte
Journal: J Clin Invest Date: 1985-05 Impact factor: 14.808

Review 5. Chronic granulomatous disease. Molecular genetics.

Authors: M C Dinauer; S H Orkin
Journal: Hematol Oncol Clin North Am Date: 1988-06 Impact factor: 3.722

6. Classification of chronic granulomatous disease.

Authors: J T Curnutte
Journal: Hematol Oncol Clin North Am Date: 1988-06 Impact factor: 3.722

7. Induction of phagocyte cytochrome b heavy chain gene expression by interferon gamma.

Authors: P E Newburger; R A Ezekowitz; C Whitney; J Wright; S H Orkin
Journal: Proc Natl Acad Sci U S A Date: 1988-07 Impact factor: 11.205

8. Clinical features and current management of chronic granulomatous disease.

Authors: C B Forrest; J R Forehand; R A Axtell; R L Roberts; R B Johnston
Journal: Hematol Oncol Clin North Am Date: 1988-06 Impact factor: 3.722

Review 9. Chronic granulomatous disease: a syndrome of phagocyte oxidase deficiencies.

Authors: A I Tauber; N Borregaard; E Simons; J Wright
Journal: Medicine (Baltimore) Date: 1983-09 Impact factor: 1.889

10. Kx: its relationship to chronic granulomatous disease and genetic linkage with Xg.

Authors: P Densen; S Wilkinson-Kroovand; G L Mandell; G Sullivan; R Oyen; W L Marsh
Journal: Blood Date: 1981-07 Impact factor: 22.113

4 in total

1. Treatment of patients with chronic granulomatous disease with recombinant human interferon-gamma does not improve neutrophil oxidative metabolism, cytochrome b558 content or levels of four anti-microbial proteins.

Authors: T J Mühlebach; J Gabay; C F Nathan; C Erny; G Dopfer; H Schroten; V Wahn; R A Seger
Journal: Clin Exp Immunol Date: 1992-05 Impact factor: 4.330

2. Granulocyte-macrophage colony stimulating factor does not improve neutrophil oxidative metabolism in a patient with variant X-linked chronic granulomatous disease.

Authors: T J Mühlebach; H J Feickert; K Welte; R A Seger
Journal: Eur J Pediatr Date: 1991-06 Impact factor: 3.183

Review 3. Interferon gamma-1b. A review of its pharmacology and therapeutic potential in chronic granulomatous disease.

Authors: P A Todd; K L Goa
Journal: Drugs Date: 1992-01 Impact factor: 9.546

4. Definition of interferon gamma-response elements in a novel human Fc gamma receptor gene (Fc gamma RIb) and characterization of the gene structure.

Authors: P D Benech; K Sastry; R R Iyer; Q G Eichbaum; D P Raveh; R A Ezekowitz
Journal: J Exp Med Date: 1992-10-01 Impact factor: 14.307

4 in total